Savara Inc.: Citizens JMP Sees 164% Price Potential in the Biotech Specialized in Rare Respiratory Diseases

Focus on Rare Respiratory Diseases Savara Inc. (SVRA) is a biotech company focused on the development and commercialization of therapies for rare respiratory diseases with high unmet medical needs. Unlike companies that target widespread diseases, Savara aims to assist patients for whom there are limited or insufficient treatment options. The company positions itself as a future market leader in this niche area. The core solution Savara currently offers its future customers is MOLBREEVI (Molgramostim inhalation solution), a recombinant granulocyte-macrophage...